Pioglitazone and metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy

INTRODUCTION: Type 2 diabetes mellitus, a metabolic disease with increasing incidence, is one of the most important cardiovascular risk factors. Insulin resistance represents the common mechanism that leads to type 2 diabetes in obese subjects. Metformin and the thiazolidinediones, pioglitazone and...

Descripción completa

Detalles Bibliográficos
Autores principales: Derosa, Giuseppe, Salvadeo, Sibilla Anna Teresa
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Place in Therapy Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012436/
https://www.ncbi.nlm.nih.gov/pubmed/21221185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012436/
https://www.ncbi.nlm.nih.gov/pubmed/21221185

Ejemplares similares